Skip to main content

Table 1 Classification of MISC and Methylprednisolone Dosing Based on Severity

From: Impact of anakinra use on clinical outcomes in children with moderate or severe multisystem inflammatory syndrome in children: a propensity score matched retrospective cohort study

 

Mild

Moderate

Severe (ICU care)

Respiratory support

None

None or minimal or significant

None or minimal or significant

Cardiovascular support

None

None or minimal

Vaso actives or inotropes

End organ injury

Minimal

Mild or isolated

Severe or multi-organ

Initial dose (mg/kg/day)

Maintenance daily dose

None or minimal

10 mg/kg (max 1 g) x 1–3 days

2 mg/kg (max 60 mg) x 5 days

20-30 mg/kg (max 1 g) x 1–3 days

2 mg/kg (max 60 mg) x 5 days